Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person4
Equillium, Inc.
Company
EQUIFAX INC
Company
EQUINIX INC
Company
CDT Equity Inc.
Company
Primary record5
Equillium, Inc. filed SCHEDULE 13G/A
0001716774-26-000029.txt : 20261104 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001716774-26-000015 0001716774 XXXXXXXX LIVE 1 Common Stock, $0.0001 Par Value 09/30/2026 0001746466 Equillium, Inc. 29446K106 22
Equillium, Inc. filed 8-K
Item 3.02 Unregistered Sales of Equity Securities. The disclosure regarding the securities sold and issued under the Securities Purchase Agreement by and among Equillium, Inc., a Delaware corporation (the “Company”) and
Equillium, Inc. filed 8-K
Item 8.01 Other Events. On October 5, 2026, Equillium, Inc. (the Company) announced that the Company has received Human Research Ethics Committee approval and clearance from the Therapeutic Goods Administration in Austra
Equillium, Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On August 13, 2026, Equillium, Inc. (the “Company”) announced its financial results for the second quarter ended June 30, 2026 in the press release attached hereto
Equillium, Inc. filed SCHEDULE 13G
on May 13, 2026. As of June 30, 2026, the Reporting Persons have sole power to vote or to direct the vote of 4,100,000 shares of Common Stock. As of June 30, 2026, the Reporting Persons have shared power to vote or to di